Filing Details
- Accession Number:
- 0001209191-20-020354
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-19 19:55:52
- Reporting Period:
- 2020-03-06
- Accepted Time:
- 2020-03-19 19:55:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1775295 | Christine Chung | C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158 | Svp, China Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-03-06 | 10,126 | $39.71 | 122,518 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2020-03-17 | 40,000 | $0.00 | 162,518 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2020-03-18 | 400 | $25.40 | 162,918 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-03-18 | 905 | $23.69 | 162,013 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-03-18 | 1,500 | $24.56 | 160,513 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-03-18 | 1,500 | $25.68 | 159,013 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-03-19 | 7,345 | $25.40 | 166,358 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-03-19 | 300 | $23.93 | 166,058 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-03-19 | 830 | $25.32 | 165,228 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-03-19 | 6,215 | $26.08 | 159,013 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | A | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-03-17 | 66,250 | $0.00 | 66,250 | $26.41 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-03-18 | 400 | $0.00 | 400 | $25.40 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-03-19 | 7,345 | $0.00 | 7,345 | $25.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
66,250 | 2030-03-17 | No | 4 | A | Direct | |
42,064 | 2027-03-08 | No | 4 | M | Direct | |
34,719 | 2027-03-08 | No | 4 | M | Direct |
Footnotes
- Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
- Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years.
- Shares sold pursuant to a 10b5-1 plan.
- The shares were sold at prices ranging from $23.10 to $24.07. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $24.13 to $25.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $25.26 to $26.25. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $23.50 to $24.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $24.71 to $25.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $25.71 to $26.525. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Twenty-five percent of the shares subject to the option vests on March 1, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years.
- Twenty-five percent of the shares subject to the option vests on March 1, 2018, and the remainder vests in equal amounts quarterly thereafter for the following three years.